Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled evaluation of cariprazine in bipolar depression
2011-002334-39Phase 2Completed
- Sponsor
- Forest Research Institute, Inc
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar I disorder comparing Cariprazine with Placebo (2 arms). Primary endpoint: Change from Baseline to Week 6 in MADRS total score. Started Jan 2012; status: completed.
02
Drugs
cariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2011-002334-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002334-39.